James Hardie Industries (JHX) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
7 Aug, 2026Executive summary
Net sales for Q1 FY27 reached $1.475 billion, up 64% year-over-year, exceeding guidance, driven by strong Siding & Trim performance and AZEK integration.
Adjusted EBITDA was $422 million (28.6% margin), up 79%, with synergy realization ahead of schedule.
Free cash flow increased 145% to $254 million, supporting deleveraging and future growth.
Europe and Australia & New Zealand delivered double-digit revenue growth.
Expanded partnerships with Boise Cascade and major regional distributors to drive channel reach and revenue synergies.
Financial highlights
Adjusted diluted EPS rose 13% to $0.36, with adjusted net income up 54% to $209 million.
Free cash flow for the quarter was $254 million, driven by higher profitability and lower capex.
Adjusted EBITDA margin improved 230bps to 28.6%.
Net leverage reduced to 2.7x after redeeming $400 million in senior unsecured notes.
Adjusted effective tax rate was 21.7%.
Outlook and guidance
Q2 FY27 net sales guidance: $1.485–$1.575 billion; adjusted EBITDA: $420–$455 million.
Full-year FY27 sales outlook raised to $5.564–$5.723 billion (5.9%–9% pro forma growth); adjusted EBITDA expected at $1.536–$1.625 billion.
Free cash flow for FY27 expected to exceed $500 million; capex at 6–7% of net sales.
Siding & Trim and Deck, Rail & Accessories segments both expected to deliver organic growth.
Latest events from James Hardie Industries
- Redesigned CEO equity grant and improved compensation structure headline annual meeting proposals.JHX
Proxy filing6 Aug 2026 - Record Q1 EBITDA and 4% sales growth achieved; FY25 guidance reaffirmed amid market headwinds.JHX
Q1 20258 Jul 2026 - Shareholders will vote on board, pay, auditor, and governance changes after a year of major transformation.JHX
Proxy filing1 Jul 2026 - Director elections, say-on-pay, auditor ratification, and governance amendments up for vote.JHX
Proxy filing1 Jul 2026 - Major acquisition, board refresh, and executive pay overhaul highlight FY26 governance and strategy.JHX
Proxy filing18 Jun 2026 - AZEK acquisition and synergy gains drove strong sales and EBITDA growth, with FY27 targets raised.JHX
Q4 202620 May 2026 - Net sales up 30% to $1.24B, with higher EBITDA and raised FY26 guidance amid synergy progress.JHX
Q3 202613 Apr 2026 - Q2 FY26 sales jumped 34% on AZEK deal; margins fell, but FY26 outlook and synergies improved.JHX
Q2 20263 Feb 2026 - H1 EBITDA topped $500m, FY25 guidance and buybacks raised despite lower sales.JHX
Q2 202514 Jan 2026